المؤلفون: Dennis J. Slamon, Thomas Bachelot, Erik Jakobsen, Rashmi Krishna Murthy, Alicia Okines, David Cameron, Lisa A. Carey, Giuseppe Curigliano, Ian E. Krop, Karen A. Gelmon, Volkmar Müller, Nan Lin, Virginia F. Borges, Eric P. Winer, Gabriel N. Hortobagyi, Philippe L. Bedard, Richard Greil, Sara A. Hurvitz, François Duhoux, Luke Walker, Sofia Braga, Elisavet Paplomata, M Corinna Palanca-Wessels, Sherene Loi, Vandana G. Abramson, Mafalda Oliveira, Carey K. Anders, Wentao Feng, Mark D. Pegram, Shlomit S. Shachar, Sibylle Loibl, Erika Hamilton

المساهمون: UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (SLuc) Unité d'oncologie médicale, UCL - (SLuc) Centre du cancer

المصدر: K Murthy, R, Loi, S, Okines, A, Paplomata, E, Hamilton, E, A. Hurvitz, S, U. Lin, N, Borges, V, Abramson, V, Anders, C, L. Bedard, P, Oliveira, M, Jakobsen, E, Bachelot, T, S. Shachar, S, Müller, V, Braga, S, P. Duhoux, F, Greil, R, Cameron, D, A. Carey, L, Curigliano, G, Gelmon, K, Hortobagyi, G, Krop, I, Loibl, S, Pegram, M, Slamon, D, Palanca-Wessels, M C, Walker, L, Feng, W & P. Winer, E 2020, ' Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer ', New England Journal of Medicine, vol. 382, no. 7, pp. 597-609 . https://doi.org/10.1056/NEJMoa1914609
Murthy, R K, Loi, S, Okines, A, Paplomata, E, Hamilton, E, Hurvitz, S A, Lin, N U, Borges, V, Abramson, V, Anders, C, Bedard, P L, Oliveira, M, Jakobsen, E, Bachelot, T, Shachar, S S, Muller, V, Braga, S, Duhoux, F P, Greil, R, Cameron, D, Carey, L A, Curigliano, G, Gelmon, K, Hortobagyi, G, Krop, I, Loibl, S, Pegram, M, Slamon, D, Palanca-Wessels, M C, Walker, L, Feng, W & Winer, E P 2020, ' Tucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancer ', New England Journal of Medicine, vol. 382, no. 7, pp. 597-609 . https://doi.org/10.1056/NEJMoa1914609
The New England journal of medicine, Vol. 382, no. 7, p. 597-609 (2020)

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Protein-Tyrosine Kinases/antagonists & inhibitors, Kaplan-Meier Estimate, 030204 cardiovascular system & hematology, Trastuzumab/administration & dosage, Capecitabine, 03 medical and health sciences, 0302 clinical medicine, Breast Neoplasms/drug therapy, Double-Blind Method, Trastuzumab, Internal medicine, medicine, Humans, 030212 general & internal medicine, Progression-free survival, skin and connective tissue diseases, neoplasms, Human Epidermal Growth Factor Receptor 2, Aged, integumentary system, business.industry, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Disease progression, Consolidation Chemotherapy, General Medicine, Middle Aged, medicine.disease, Metastatic breast cancer, Progression-Free Survival, Multicenter study, Capecitabine/administration & dosage, Receptor, ErbB-2/analysis, Brain Neoplasms/secondary, Diarrhea/chemically induced, Female, business, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5309a1bc026281d5d475def4ba6ca36
https://www.pure.ed.ac.uk/ws/files/125147047/NEJMoa1914609.pdf